Manufacturer record
Jackson Laboratories Pvt. Ltd: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
78 batches manufactured by Jackson Laboratories Pvt. Ltd (Punjab) were declared Not of Standard Quality between January 2019 and July 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
78 records linked to Jackson Laboratories Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Phenytoi Tablets IP 100mg | T-4710Mfg 2025-03 · Exp 2027-02 | The sample has been declared as NSQ quality with respect to Description.Description | RDTL. Bellary KarnatakaState lab | Jul 2026 |
| Oxytocin Injection IP 5IU/ml | I-7881Mfg 2025-11 · Exp 2027-10 | The sample does not conform to claim as per IP 2022 in respect to the Test of Identification by HPLC and Particulate MatterIdentification | RDTL, ChandigarhCDSCO lab | Jul 2026 |
| Pantoprazole Gastro Resistant Tablets IP 40mg | T-3423Mfg 2024-11 · Exp 2026-10 | Does not conform to IP Standards with respect to Description and Dissolution TestDissolution | FDL, Bambolim GoaState lab | Jun 2026 |
| Oxytocin Injection IP 5 IU/ml | I-7881Mfg 2025-11 · Exp 2027-10 | The sample does not conform to the IP as it does not contain Oxytocin (Synthetic) Nil.Other | DTL, JaipurState lab | May 2026 |
| Dicloxacillin Capsules IP 500 mg | C-3140Mfg 2024-10 · Exp 2026-09 | The sample does not conform to I.P with respect to the tests of water, Dissolution and Assay of Dicloxacillin.Assay | CDL, KolkataCDSCO lab | Mar 2026 |
| Phenytoin Tablets IP 100 mg | T-5616Mfg 2025-04 · Exp 2027-03 | The sample fails in the Test for Description of Tablets.Description | MDTL Kathua, Jammu and KashmirState lab | Jan 2026 |
| Chlorpheniramine Tablets IP 4mg | T-6763Mfg 2025-08 · Exp 2027-07 | Failed in DissolutionDissolution | DTL, PuducherryState lab | Oct 2025 |
| Cefuroxime Axetil Tablets IP 500mg | T-21544Mfg 2024-10 · Exp 2026-09 | Dissolution of CefuroximeDissolution | RDTL, GuwahatiCDSCO lab | Jul 2025 |
| Cefuroxime Axetil Tablets IP 500mg | T-21172Mfg 2024-07 · Exp 2026-06 | Dissolution of CefuroximeDissolution | RDTL, GuwahatiCDSCO lab | Jul 2025 |
| Macro Ampicloxa (Ampicillin & Cloxacillin Capsules) | C-20404Mfg 2024-02 · Exp 2026-01 | Content of Ampicillin in Ampicillin Trihydrate and Cloxacillin in Cloxacillin SodiumOther | DTL MaduraiState lab | Jun 2025 |
| Vitamin B-Complex with Vitamin C and Biotin Capsules (Vitabon ) | C-3465Mfg 2024-11 · Exp 2026-10 | Assay/content of Calcium PantothenateAssay | CDL, KolkataCDSCO lab | May 2025 |
| Sitagliptin & Metformin Tablets 50 mg + 1000 mg (Sitajack-M ) | T-2916Mfg 2024-09 · Exp 2026-08 | Assay of SitagliptinAssay | CDL, KolkataCDSCO lab | May 2025 |
| Fexofenadine Tablets IP (Fexodil 180 mg) | T-4029Mfg 2025-01 · Exp 2026-12 | Dissolution test after 10 min and after 30 minDissolution | CDL, KolkataCDSCO lab | May 2025 |
| Telmisartan & Hydrochlorothiazide Tablets IP (Telmijack-H) | T-20560Mfg 2024-03 · Exp 2026-02 | "Related substances and Assay of Hydrochlorothiazi de"Assay | CDTL MumbaiCDSCO lab | Apr 2025 |
| Pantoprazole Gastro- Resistant Tablets IP 40 mg (Pantojack-40) | T-1261Mfg 2024-04 · Exp 2026-03 | Description and DissolutionDissolution | RDTL, GuwahatiCDSCO lab | Mar 2025 |
| Fexofenadine Tab IP [Fexodil-180] | T ? 3105Mfg 2024-10 · Exp 2026-09 | It fails the test ?Dissolution? as per IPDissolution | Drugs Testing Laboratory ThiruvananthapuramState lab | Mar 2025 |
| Nitrofurantoin Tablets IP 100mg | T-2485Mfg 2023-11 · Exp 2025-10 | DissolutionDissolution | RDTL GuwahatiCDSCO lab | Feb 2025 |
| Fexofenadin e Hydrochlori de Tab IP 180 mg [Fexodil- 180] | T 3105Mfg 2024-10 · Exp 2026-09 | It fails the test ?Dissolution? as per IPDissolution | DTL ThiruvananthapuramState lab | Jan 2025 |
| BETAHISTI NE DIHYDROC HLORIDE TABLETS IP (Betahox- 8) | T-18946Mfg 2023-02 · Exp 2025-01 | On the received sample presence of spots were observed which should not be present As per DCC Guidelines on Not Of Standard Quality (NSQ) Drugs Approved in 1993 (Annexure A) Tablets vide serial No.(i) Presence of Spot/discolouration. - NSQDescription | State Lab PuducherryState lab | Jan 2025 |
| Albendazole Tablets IP 400 mg (Albendazole 400) | T-3159Mfg 2024-01 · Exp 2025-12 | DissolutionDissolution | RDTL GuwahatiCDSCO lab | Jan 2025 |
| Rabeprazole Gastro-resistant Tablets IP 20 mg (Robijick - 20) | T- 1047Mfg 2023-06 · Exp 2025-05 | "Dissolution (Acid stage) & (Buffer stage) and Description"Dissolution | CDTL MumbaiCDSCO lab | Dec 2024 |
| PRIMAQUINE PHOSPHATE TABLETS IP 2.5 mg | T-1338Mfg 2023-07 · Exp 2025-06 | Dissolution and AssayAssay | RDTL GuwahatiCDSCO lab | Dec 2024 |
| Pantoprazole Gastro- Resistant Tablets IP 40 mg (Pantojack- 40) | T-1261Mfg 2024-04 · Exp 2026-03 | Dissolution & DescriptionDissolution | RDTL GuwahatiCDSCO lab | Nov 2024 |
| Ramipril Tablets IP 5 mg. (Ramil- 5) | T-5987Mfg 2023-01 · Exp 2024-12 | DissolutionDissolution | RDTL GuwahatiState lab | Mar 2024 |
| Multi-Vitamin Tablets (VITAJACKS-S TABLETS) | T-171Mfg 2023-04 · Exp 2025-03 | Assay of Vitamin B1 and Vitamin C.Assay | RDTL ChandigarhCDSCO lab | Dec 2023 |
| Methylergometrine Injection IP (0.2mg/ml) | I-6067Mfg 2023-01 · Exp 2024-12 | Bacterial endotoxinsBacterial endotoxins | RDTL GuwahatiState lab | Dec 2023 |
| ARTESUNATE INJECTION IP (ZYNATE) | I-1219Mfg 2023-07 · Exp 2025-06 | Bacterial Endotoxin Test, Particulate Matter & Clarity of solutionParticulate matter | CDL KolkataCDSCO lab | Nov 2023 |
| Pyrazinamide Tablets IP 500 mg, (Pyrazinamide- 500) | T-5674Mfg 2022-12 · Exp 2024-11 | Description & DissolutionDissolution | CDL KolkataCDSCO lab | Oct 2023 |
| Rabeprazole Gastro- Resistant Tablets I.P. 20 mg.(Robijack 20 mg.), | T-6670Mfg 2023-03 · Exp 2025-02 | DissolutionDissolution | RDTL GuwahatiState lab | Sep 2023 |
| Pyrazinamide Tablets IP 500mg (Pyrazinamide-500) | T-5969Mfg 2022-12 · Exp 2024-11 | DissolutionDissolution | CDL KolkataCDSCO lab | Sep 2023 |
| Esylate (Etamsylate Injection 250 mg) | I-2359Mfg 2021-12 · Exp 2023-11 | Description, Particulate Matter & Extractable VolumeDescription | CDL KolkataCDSCO lab | Aug 2023 |
| Amoxycillin Capsules IP 500 MG (AMOXYCILLIN 500) | C-5076Mfg 2022-10 · Exp 2024-09 | TEST FOR DISSOLUTIONDissolution | CDTL ChennaiCDSCO lab | Aug 2023 |
| Bupivacaine Heavy (Bupivacaine Hydrochloride in Dextrose Injection USP 4 ml), | I?5319Mfg 2022-10 · Exp 2024-09 | Description Foreign and Particulate matterDescription | CDL KolkataCDSCO lab | May 2023 |
| Omitan ? 20 (Olmesartan Medoxomil Tablets I.P.) | T-3567Mfg 2022-04 · Exp 2024-03 | Dissolution & AssayAssay | CDL KolkataCDSCO lab | Apr 2023 |
| Phenytoin Sodium Tablets IP 100 mg | T-23953Mfg 2021-02 · Exp 2023-01 | DescriptionDescription | RDTL GuwahatiState lab | Jan 2023 |
| Bupivacaine Hydrochloride Injection IP (0.5% w/v) ? 20 ml | I-1088Mfg 2021-07 · Exp 2023-06 | Description, Particulate Matter & SterilityDescription | CDL KolkataCDSCO lab | Nov 2022 |
| FENTANYL INJECTION IP | I-1646Mfg 2021-09 · Exp 2023-08 | Particulate matter Bacterial Endotoxins and SterilitySterility | RDTL ChandigarhCDSCO lab | Mar 2022 |
| Amoxicillin and Potassium Clavulanate Tablets IP | T-22286Mfg 2020-05 · Exp 2022-04 | AssayAssay | RDTL GuwahatiState lab | Mar 2022 |
| Ceftriaxone Injection IP | I.269Mfg 2021-04 · Exp 2023-03 | Clarity of Solution & Particulate matterParticulate matter | RDTL GuwahatiState lab | Jan 2022 |
| Dexamethasone Sodium Phosphate Injection IP | I-131Mfg 2021-04 · Exp 2023-03 | AssayAssay | RDTL GuwahatiState lab | Dec 2021 |
| Norfloxacin Tablets I.P. 400 mg | T-23680Mfg 2021-01 · Exp 2022-12 | DissolutionDissolution | CDTL MumbaiCDSCO lab | Sep 2021 |
| Fluoxetine Capsules IP 20 mg | I-21800Mfg 2020-03 · Exp 2022-02 | Uniformity of filled weightUniformity of weight/content | RDTL ChandigarhCDSCO lab | Sep 2021 |
| DIVIRON-50 TABLETS (DICLOFENAC SODIUM TABLETS IP 50 mg) | T-23089Mfg 2020-10 · Exp 2022-09 | DisintegrationDisintegration | CDTL HyderabadState lab | Sep 2021 |
| ASPIRIN TABLETS I.P (Dilsprin 75) | T-20902Mfg 2019-11 · Exp 2021-10 | DescriptionDescription | RDTL GuwahatiState lab | Jun 2021 |
| Primaquine Phosphate I.P. 2.5 mg | T-22109Mfg 2020-04 · Exp 2022-03 | Dissolution and Assay TestAssay | RDTL GuwahatiCDSCO lab | May 2021 |
| Clonazepam Tablets I.P. (Clozep 0.5 mg) | T-19281Mfg 2019-04 · Exp 2022-03 | DissolutionDissolution | CDL KolkataCDSCO lab | May 2020 |
| Enaril-2.5 mg (Enalapril Maleate Tablets I.P.). | T - 19831Mfg 2019-06 · Exp 2021-05 | Dissolution and AssayAssay | CDL KolkataCDSCO lab | Apr 2020 |
| Enalapril Maleate Tablets IP 5 mg (ENARIL-5 TABLETS ) | T-20140Mfg 2019-08 · Exp 2021-07 | AssayAssay | RDTL ChandigarhCDSCO lab | Apr 2020 |
| Phenytoin Sodium Tablets I.P. 100 mg | T?18909Mfg 2019-02 · Exp 2021-01 | Assay and DescriptionAssay | CDL KolkataCDSCO lab | Feb 2020 |
| Glyjack ? 1 (Glimepiride Tablets I.P.) | T?19598Mfg 2019-05 · Exp 2021-04 | DissolutionDissolution | CDL KolkataCDSCO lab | Feb 2020 |
| Fexodil 120 mg (Fexofenadine Hydrochloride Tablets) | T?18839Mfg 2019-02 · Exp 2021-01 | DissolutionDissolution | CDL KolkataCDSCO lab | Feb 2020 |
| Zinco (Zinc Sulphate Dispersible Tablets IP) | T-20152Mfg 2019-08 · Exp 2021-07 | DisintegrationDisintegration | CDTL MumbaiCDSCO lab | Dec 2019 |
| Domperidone Tablets IP 10 mg (Domidon-10 Tablets) | T-19066Mfg 2019-03 · Exp 2021-02 | Identification A.Identification | RDTL ChandigarhCDSCO lab | Dec 2019 |
| Diclofenac Sodium Injection I.P. | I-18165Mfg 2018-11 · Exp 2020-10 | Description, Particulate Matter & pHDescription | CDL KolkataCDSCO lab | Dec 2019 |
| Cefadroxil Tablets I.P. 500mg. (Cedoxil-500) | T-16549Mfg 2018-03 · Exp 2020-02 | DissolutionDissolution | RDTL GuwahatiState lab | Dec 2019 |
| Cedoxil 500mg Tablets | T-16549Mfg 2018-03 · Exp 2020-02 | DissolutionDissolution | RDTL GuwahatiState lab | Nov 2019 |
| Enaril (Enalapril Maleate Tablets I.P. 5mg) | T-17395Mfg 2018-07 · Exp 2020-06 | Assay & DissolutionAssay | CDTL MumbaiCDSCO lab | Oct 2019 |
| Ranitidine Injection I.P. | I-17347Mfg 2018-07 · Exp 2020-06 | Particulate MatterParticulate matter | CDL KolkataCDSCO lab | Sep 2019 |
| Dispersible Paracetamol Tablets B.P. 250 mg | T-17517Mfg 2018-07 · Exp 2020-06 | Fineness of DispersionOther | CDL KolkataCDSCO lab | Sep 2019 |
| Climox 1.2g (Amoxycillin & Potassium Clavulanate Injection I.P.) | I-17225Mfg 2018-06 · Exp 2020-05 | Assay of Potassium ClavulanateAssay | CDL KolkataCDSCO lab | Aug 2019 |
| Diclofenac Sodium Injection I.P. | I-17507Mfg 2018-07 · Exp 2020-06 | Description & Particulate MatterDescription | CDL KolkataCDSCO lab | Jul 2019 |
| PRIMAQUINE PHOSPHATE TABLETS IP 2.5 MG) | T-17648Mfg 2018-08 · Exp 2020-07 | DissolutionDissolution | RDTL ChandigarhState lab | May 2019 |
| Menadione Sodium Bisulphate Injection IP (1966) 10mg/ml (VITAMIN K3 INJECTION) | I-17549Mfg 2018-08 · Exp 2020-07 | Particulate matterParticulate matter | RDTL ChandigarhCDSCO lab | May 2019 |
| Oxytocin Injection I.P. | I-16999Mfg 2018-05 · Exp 2020-04 | Description, Particulate Matter, Extractable Volume & AssayAssay | CDL KolkataCDSCO lab | Apr 2019 |
| Climox 1.2g (Amoxycillin & Potassium Clavulanate Injection I.P.), | I-16813Mfg 2018-04 · Exp 2020-03 | Particulate Matter & Clarity of SolutionParticulate matter | CDL KolkataCDSCO lab | Apr 2019 |
| B-COMPLEX TABLETS NFI | T-17313Mfg 2018-07 · Exp 2020-06 | Identification B and the Assay of Calcium PantothenateAssay | RDTL ChandigarhState lab | Apr 2019 |
| B-COMPLEX TABLETS NFI | T-17377Mfg 2018-07 · Exp 2020-06 | Identification B and the Assay of Calcium Pantothenate.Assay | RDTL ChandigarhState lab | Apr 2019 |
| NEOSTIGMINE METHYL SULPHATE INJECTION IP | I-16336Mfg 2018-03 · Exp 2020-02 | Particulate matter, SterilitySterility | RDTL ChandigarhState lab | Mar 2019 |
| Metochlopramide Hydrochloride Injection IP | I-17259Mfg 2018-06 · Exp 2020-05 | Particulate matter, Related SubstancesParticulate matter | RDTL ChandigarhCDSCO lab | Mar 2019 |
| HYOSCINE BUTYL BROMIDE INJECTION IP 20 MG | I-16603Mfg 2018-04 · Exp 2020-03 | Particulate matter and the Assay of HyoscineButylbr omideAssay | RDTL ChandigarhCDSCO lab | Mar 2019 |
| DEXAMETHASONE SODIUM PHOSPHATE Injection I.P. | I-15826Mfg 2017-12 · Exp 2019-11 | SpuriousSpurious | RDTL GuwahatiState lab | Mar 2019 |
| Cloxacillin Sodium Injection IP ( CLOXACILLIN INJECTION ) | I-16935Mfg 2018-05 · Exp 2020-04 | Assay of Cloxacillin Sodium calculated as CloxacillinAssay | RDTL ChandigarhCDSCO lab | Mar 2019 |
| PHENOBARBITAL ORAL SOLUTION USP | SY-17200Mfg 2018-06 · Exp 2020-05 | Alcohol Determination.Other | Drug Control Jammu & KashmirCDSCO lab | Feb 2019 |
| Ketorolac Tromethamine Injection I.P. 1 ml, | I-4754Mfg 2017-03 · Exp 2019-02 | Description and Particulate MatterDescription | CDSCO, East Zone, KolkataState lab | Feb 2019 |
| Clopidogrel and Aspirin Tablets (CLOPIJACK-A TABLETS) | T-16413Mfg 2018-03 · Exp 2020-02 | Salicylic acid and Assay of Clopidogrel Bisulphate calculated as Clopidogrel, AspirinAssay | RDTL ChandigarhCDSCO lab | Feb 2019 |
| (CALCIUM GLUCONATE INJECTION IP 10% W/V)?, | I-17041Mfg 2018-05 · Exp 2020-04 | Particulate matterParticulate matter | RDTL ChandigarhCDSCO lab | Feb 2019 |
| (CALCIUM GLUCONATE INJECTION IP 10% W/V) | I-17933Mfg 2018-10 · Exp 2020-09 | Bacterial endotoxinsBacterial endotoxins | RDTL ChandigarhCDSCO lab | Feb 2019 |
| Promethazine Hydrochloride Injection I.P. 25mg ? 2 ml | I-15314Mfg 2017-10 · Exp 2019-09 | Description and Particulate MatterDescription | CDL KolkataCDSCO lab | Jan 2019 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.